[go: up one dir, main page]

FI20010019L - Menetelmä atrofisen diagnostisoimiseksi - Google Patents

Menetelmä atrofisen diagnostisoimiseksi Download PDF

Info

Publication number
FI20010019L
FI20010019L FI20010019A FI20010019A FI20010019L FI 20010019 L FI20010019 L FI 20010019L FI 20010019 A FI20010019 A FI 20010019A FI 20010019 A FI20010019 A FI 20010019A FI 20010019 L FI20010019 L FI 20010019L
Authority
FI
Finland
Prior art keywords
atrophic
diagnosing
diagnosing atrophic
Prior art date
Application number
FI20010019A
Other languages
English (en)
Swedish (sv)
Other versions
FI20010019A7 (fi
FI20010019A0 (fi
Inventor
Osmo Suovaniemi
Matti Haerkoenen
Tapani Tiusanen
Pentti Sipponen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20010019A priority Critical patent/FI20010019L/fi
Publication of FI20010019A0 publication Critical patent/FI20010019A0/fi
Priority to JP2002554731A priority patent/JP4348083B2/ja
Priority to US10/451,742 priority patent/US7358062B2/en
Priority to PCT/FI2002/000008 priority patent/WO2002054084A1/en
Priority to CN028034953A priority patent/CN1484765B/zh
Priority to EP02716100A priority patent/EP1348129A1/en
Priority to RU2003124185/15A priority patent/RU2262706C2/ru
Publication of FI20010019A7 publication Critical patent/FI20010019A7/fi
Publication of FI20010019L publication Critical patent/FI20010019L/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20010019A 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi FI20010019L (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20010019A FI20010019L (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi
JP2002554731A JP4348083B2 (ja) 2001-01-05 2002-01-04 萎縮性胃炎の検査方法
US10/451,742 US7358062B2 (en) 2001-01-05 2002-01-04 Method for diagnosing atrophic gastritis
PCT/FI2002/000008 WO2002054084A1 (en) 2001-01-05 2002-01-04 A method for diagnosing atrophic gastritis
CN028034953A CN1484765B (zh) 2001-01-05 2002-01-04 一种用于诊断萎缩性胃炎的方法
EP02716100A EP1348129A1 (en) 2001-01-05 2002-01-04 A method for diagnosing atrophic gastritis
RU2003124185/15A RU2262706C2 (ru) 2001-01-05 2002-01-04 Способ для диагностики атрофических гастритов

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010019A FI20010019L (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi

Publications (3)

Publication Number Publication Date
FI20010019A0 FI20010019A0 (fi) 2001-01-05
FI20010019A7 FI20010019A7 (fi) 2002-07-06
FI20010019L true FI20010019L (fi) 2002-07-06

Family

ID=8559891

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010019A FI20010019L (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi

Country Status (7)

Country Link
US (1) US7358062B2 (fi)
EP (1) EP1348129A1 (fi)
JP (1) JP4348083B2 (fi)
CN (1) CN1484765B (fi)
FI (1) FI20010019L (fi)
RU (1) RU2262706C2 (fi)
WO (1) WO2002054084A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102533972B (zh) 2002-05-09 2014-07-02 布赖汉姆妇女医院 作为心血管病的标志和治疗靶的1l1rl-1
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
EP1608984A2 (en) * 2003-03-28 2005-12-28 Aphton Corporation Gastrin hormone immunoassays
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
EP1577673B1 (en) * 2004-03-15 2008-07-30 F. Hoffmann-La Roche Ag The use of BNP-type peptides and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
CN101163971B (zh) * 2004-12-20 2013-03-20 免疫体公司 测定作为肾病诊断标记物的嗜中性粒细胞明胶酶相关性脂笼蛋白
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US20080090304A1 (en) * 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
EP1978867B1 (en) * 2006-06-05 2011-05-25 Forth Photonics Limited Methods for characterizing tissues
EP2602624A1 (en) * 2006-08-07 2013-06-12 Antibodyshop A/S Diagnostic test to exclude significant renal injury
US20080050749A1 (en) * 2006-08-17 2008-02-28 Ildiko Amann-Zalan Use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
RU2321857C1 (ru) * 2006-12-28 2008-04-10 ГОУ ВПО Смоленская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию Российской Федерации Способ диагностики состояния антрального отдела слизистой оболочки желудка у детей и подростков
RU2331364C1 (ru) * 2007-03-05 2008-08-20 ФГУ "Нижегородский НИИ детской гастроэнтерологии Росздрава" Способ диагностики гастрита у детей
EP2557425A3 (en) 2007-10-26 2013-07-10 Biohit Oyj Methods and products for diagnosing autoimmune diseases and gastric cancer linked with atrophic gastritis
WO2009129454A2 (en) 2008-04-18 2009-10-22 Critical Care Diagnostics, Inc. Predicting risk of major adverse cardiac events
CN102227641B (zh) * 2008-10-01 2015-04-22 亚利桑那大学评议会 葡糖苷酸化的对乙酰氨基酚作为肝脏疾病的标志
WO2010118539A2 (en) * 2009-04-14 2010-10-21 Biocartis Sa Hifu induced cavitation with reduced power threshold
RU2394499C1 (ru) * 2009-06-09 2010-07-20 Эльвира Ивановна Белобородова Способ диагностики степени активности антрального хеликобактер-ассоциированного гастрита у больных бронхиальной астмой
RU2429789C1 (ru) * 2010-01-25 2011-09-27 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ определения степени атрофии слизистой оболочки антрального отдела и/или тела желудка
CN102087279A (zh) * 2010-03-11 2011-06-08 北京美康生物技术研究中心 一种联合诊断胃病或评价胃癌风险的酶联免疫吸附试剂盒
US20130056630A1 (en) * 2010-05-03 2013-03-07 The Cleveland Clinic Foundation Detection and monitoring of nonalcoholic fatty liver disease
WO2011151783A1 (en) * 2010-05-31 2011-12-08 University Hospital Of Basel Method for assaying lower respiratory tract infection or inflammation
ES2372842B1 (es) * 2010-07-12 2013-08-13 Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe Método ex-vivo para el diagnóstico temprano de la encefalopatía hepática mínima mediante la determinación de 3-nitrotirosina en suero.
RU2465597C1 (ru) * 2011-04-08 2012-10-27 Сергей Михайлович Котелевец Способ определения вероятности развития рака желудка
AU2013305829A1 (en) 2012-08-21 2015-03-05 Critical Care Diagnostics, Inc. Multimarker risk stratification
CN103914997B (zh) * 2014-04-02 2016-03-02 无锡宜偌维盛生物技术有限公司 一种胃功能演示仪
FI20145550A7 (fi) * 2014-06-13 2015-12-14 Biohit Oyj Gastriini-17 käyttö biomarkkerina atrofiselle gastriitille ja usealle sen seurauksena kohonneelle riskille
RU2560703C1 (ru) * 2014-09-17 2015-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт молекулярной биологии и биофизики" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИМББ" СО РАМН) Способ выявления дисплазии эпителия слизистой оболочки желудка у пациентов с атрофическим гастритом или аденомой желудка
RU2584750C1 (ru) * 2015-05-22 2016-05-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт молекулярной биологии и биофизики" (НИИМББ) Способ выявления дисплазии эпителия слизистой оболочки желудка при ее атрофических изменениях
CN106198986A (zh) * 2016-08-31 2016-12-07 潍坊市康华生物技术有限公司 联合诊断胃病的化学发光检测试剂盒及其制备、使用方法
EP3296746A1 (en) * 2016-09-20 2018-03-21 Université de Bourgogne In vitro method for diagnosing at early stage intestinal ischemia
JP6885581B2 (ja) * 2017-02-06 2021-06-16 学校法人東京歯科大学 ガストリン測定におけるカットオフ値の推定方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656025A (en) * 1985-04-19 1987-04-07 Emmanuel Deutsch Quantitative screening assay of tumor globulin from gastric juice
SU1704013A1 (ru) * 1988-07-12 1992-01-07 Запорожский государственный институт усовершенствования врачей им.М.Горького Способ диагностики атрофического антрального гастрита
JP3920320B2 (ja) * 1992-02-26 2007-05-30 ヴァンダービルト ユニバーシティ 精製されたＨｅｌｉｃｏｂａｃｔｅｒ ｐｙｌｏｒｉ由来の空胞形成毒素およびその使用方法
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
CN1178523A (zh) * 1995-03-14 1998-04-08 第一制药株式会社 氨基酚衍生物
JP2949474B2 (ja) 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
US6852487B1 (en) * 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
FI990991A7 (fi) * 1999-04-30 2000-10-31 Biohit Oyj Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
US7179609B1 (en) * 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis

Also Published As

Publication number Publication date
WO2002054084A8 (en) 2003-01-30
US7358062B2 (en) 2008-04-15
FI20010019A7 (fi) 2002-07-06
US20040038376A1 (en) 2004-02-26
JP2004517322A (ja) 2004-06-10
JP4348083B2 (ja) 2009-10-21
EP1348129A1 (en) 2003-10-01
WO2002054084A1 (en) 2002-07-11
CN1484765A (zh) 2004-03-24
RU2003124185A (ru) 2005-01-10
RU2262706C2 (ru) 2005-10-20
CN1484765B (zh) 2012-07-18
FI20010019A0 (fi) 2001-01-05

Similar Documents

Publication Publication Date Title
FI20010019L (fi) Menetelmä atrofisen diagnostisoimiseksi
BRPI0313238A2 (pt) método
FI20012271L (fi) Menetelmä vastinpisteiden määrittämiseksi
ATE286866T1 (de) Fischer-tropschverfahren
FI20012603L (fi) Diagnostinen menetelmä
DE60229840D1 (de) Offset-messverfahren
NO20023358D0 (no) Metode
DE60226093D1 (de) Urmedium-Reinigungsmethode
FI20010221A0 (fi) Menetelmä entsyymin uuttamiseksi
FI20011252L (fi) Rakennusmenetelmä
FI20012608A0 (fi) Diagnostiset menetelmät
DE50115802D1 (de) Dafür
NO20015802D0 (no) Diagnostisk metode
FI20010662L (fi) Menetelmä yhteydenottojen hallitsemiseksi
SE0104471D0 (sv) New method
SE0100171L (sv) Provförfarande
SE0102004D0 (sv) Indiviva-metoden
DOP2001000312A (es) Metodo
SE0100899D0 (sv) Method
SE0100900D0 (sv) Method
SE0101479D0 (sv) Method
FI20002225A0 (fi) Diagnostinen menetelmä
SE0103416D0 (sv) New method
SE0103357D0 (sv) New method
SE0201055D0 (sv) New method

Legal Events

Date Code Title Description
FC Application refused